Journal Article

P-382GC1118, an anti-EGFR monoclonal antibody, blocks irinotecan-induced EGFR activation and exhibits synergistic tumor regression in gastric cancer model

Jae-Chul Lee, Hyung Jun Cho, Minkyu Hur, Yangmi Lim, Shi-Nai Lee, Eun Hee Lee, Jonghwa Won and Minkyu Hur

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 28, issue suppl_3 Published in print June 2017 | ISSN: 0923-7534
Published online June 2017 | e-ISSN: 1569-8041 | DOI: https://dx.doi.org/10.1093/annonc/mdx261.378
P-382GC1118, an anti-EGFR monoclonal antibody, blocks irinotecan-induced EGFR activation and exhibits synergistic tumor regression in gastric cancer model

Show Summary Details

Journal Article.  307 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.